Drug · DIN 02306085
VALCYTE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 19, 2022; first marketed August 13, 2008.
- Drug Identification Number (DIN)
- 02306085
- Company (DIN owner)
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Oral
- Therapeutic class (ATC)
- Valganciclovir J05AB14
- Class
- Human
- Record last updated
- July 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE) | 50 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 11, 2022: NOC 28567New Drug Submission (NDS) · Administrative: Change in Product Ownership
- March 7, 2008: NOC 9417Supplement to a New Drug Submission (SNDS) · New dosage form
Other DINs named VALCYTE
- DIN 02245777 · Marketed